Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to determine if patient's own Continuous Glucose Monitor (CGMs) worn in the non-ICU hospital setting have adequate accuracy for blood glucose monitoring when compared to point-of-care (POC) capillary glucose measurement, and to determine if alerts given by CGMs worn in the non-ICU hospital would prevent episodes of hyperglycemia and hypoglycemia.
Description: MARD will be calculated between matched pairs of POC (point of care) glucose monitors and the closest CGM reading. MARD will be summarized as mean (standard deviation) or median (range) for glucose readings <70g/dl, >180g/dl, >250g/dl respectively.
Measure: CGM accuracy - mean absolute relative difference (MARD) Time: From date of enrollment and until discharge from the hospital up to 30 days.Description: The incidence and duration of hypoglycemic episodes
Measure: CGM recorded hypoglycemia episodes Time: From date of enrollment and until discharge from the hospital up to 30 days.Description: The incidence and duration of hyperglycemic episodes
Measure: CGM recorded hyperglycemia episodes. Time: From date of enrollment and until discharge from the hospital up to 30 days.Description: The effect of antibiotics, glucocorticoids, vasopressors, dose of immunosuppressive medications, hypotension/hypertension, hypoxemia, lactic acidosis on CGM accuracy.
Measure: Variation in MARD in relation to pharmacological and physiological parameters Time: From date of enrollment and until discharge from the hospital up to 30 days.Description: Mortality during index hospitalization
Measure: In hospital mortality Time: From date of admission and until discharge from the hospital up to 30 days.Description: Duration of hospital stay in days.
Measure: Hospitalization length of stay Time: From date of admission and until discharge from the hospital up to 30 days.Description: Number of patients that got readmitted to the hospital after discharge following the index hospitalization.
Measure: Readmission rate at 30 days Time: 30 days post discharge from hospital.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports